Table II.
Group | N | 1 day | 7 days | 14 days |
---|---|---|---|---|
S | 19 | 0 | 0 | 0 |
M | 38 | 5.47±0.89a | 4.95±0.96a | 3.58±0.79a |
EM | 38 | 5.34±0.94 | 4.21±0.58b | 2.61±0.82b |
IM | 38 | 5.55±0.83 | 5.58±0.92b | 4.26±0.89b |
IEM | 38 | 5.29±0.90 | 4.89±0.83c | 2.81±0.90 |
Data were presented as mean ± standard deviation, ANOVA.
P<0.05 vs. the same period of S.
P<0.05 vs. the same period of M.
P<0.05 vs. the same period of EM.
S group, sham operation group; M group, model group; EM group, treadmill training model group; IM group, inhibitor treatment model group; IEM group, Inhibitor treatment and treadmill training model group.